01.10.1997 | ORIGINAL PAPER
p53 nuclear immunoreactivity as a predictor of response and outcome following chemotherapy for metastatic bladder cancer
Erschienen in: Journal of Cancer Research and Clinical Oncology | Ausgabe 10/1997
Einloggen, um Zugang zu erhalten